Hussman Strategic Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $384 Million
- Q1 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 84,000 shares of HRMY stock, worth $2.52 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
84,000
Previous 84,000
-0.0%
Holding current value
$2.52 Million
Previous $2.89 Million
3.56%
% of portfolio
0.73%
Previous 0.9%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
262Shares Held
45.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$198 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$175 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$142 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.45MShares$43.4 Million2.2% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.77B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...